Table 1 Material blank control group, GelMA/DBM group and GelMA/DBM/DFO group blood routine and liver and kidney function indexes at 4, 8 and 12 weeks after surgery.

From: Enhancement of in vitro and in vivo bone repair performance of decalcified bone/gelma by desferrioxamine

 

Test index

Blank

GelMA/DBM

GelMA/DBM/DFO

P value

4w

WBC (109/L)

10.32 ± 0.63

9.45 ± 0.44

10.13 ± 0.34

P = 0.15

RBC (1012/L)

8.21 ± 0.10

8.18 ± 0.21

7.99 ± 0.16

P = 0.27

HB (g/L)

157.00 ± 7.81

153.00 ± 5.29

154.00 ± 4.36

P = 0.71

PLT (109/L)

847.0 ± 22.34

860.67 ± 32.65

873.33 ± 32.87

P = 0.58

ALT (U/L)

50.00 ± 8.89

45.33 ± 8.96

51.67 ± 13.20

P = 0.76

AST (U/L)

117.3 ± 25.01

137.67 ± 4.51

128.33 ± 7.57

P = 0.33

Urea (mmol/L)

5.30 ± 0.59

4.84 ± 0.44

5.78 ± 1.08

P = 0.35

Cr (µmol/L)

33.67 ± 3.51

32.33 ± 3.51

35.67 ± 6.11

P = 0.68

8 W

WBC (109/L)

13.41 ± 0.29

12.97 ± 1.68

12.97 ± 0.53

P = 0.83

RBC (1012/L)

8.15 ± 0.52

8.05 ± 0.42

7.88 ± 0.99

P = 0.89

HB (g/L)

167.0 ± 11.36

163.00 ± 8.89

154.33 ± 15.37

P = 0.47

PLT (109/L)

922.0 ± 86.02

970.67 ± 124.23

962.67 ± 96.10

P = 0.83

ALT (U/L)

53.67 ± 8.39

45.67 ± 7.77

53.33 ± 11.06

P = 0.52

AST (U/L)

106.0 ± 13.08

119.00 ± 22.87

126.67 ± 13.61

P = 0.39

Urea (mmol/L)

5.18 ± 0.40

4.81 ± 0.47

5.65 ± 0.44

P = 0.14

Cr (µmol/L)

28.67 ± 2.08

32.00 ± 3.61

35.00 ± 3.61

P = 0.13

WBC (109/L)

10.43 ± 0.50

9.80 ± 0.34

9.61 ± 0.23

P = 0.08

RBC (1012/L)

8.39 ± 0.11

8.47 ± 0.13

8.16 ± 0.22

P = 0.13

12 W

HB (g/L)

157.67 ± 4.16

154.67 ± 2.52

157.00 ± 6.08

P = 0.71

PLT (109/L)

902.0 ± 68.64

950.00 ± 85.56

911.67 ± 39.43

P = 0.67

ALT (U/L)

50.67 ± 10.26

46.67 ± 4.51

51.00 ± 6.24

P = 0.74

AST (U/L)

127.00 ± 9.17

126.00 ± 9.85

128.67 ± 3.79

P = 0.92

Urea (mmol/L)

4.98 ± 0.65

5.12 ± 0.30

5.16 ± 0.30

P = 0.87

Cr (µmol/L)

29.67 ± 4.04

35.00 ± 8.00

33.33 ± 5.51

P = 0.58

Back to article page